These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10816622)

  • 41. Detection of melanoma cells in sentinel lymph nodes by reverse transcriptase-polymerase chain reaction: prognostic significance.
    Gradilone A; Ribuffo D; Silvestri I; Cigna E; Gazzaniga P; Nofroni I; Zamolo G; Frati L; Scuderi N; Aglianò AM
    Ann Surg Oncol; 2004 Nov; 11(11):983-7. PubMed ID: 15525827
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lymph node micrometastases of cutaneous melanoma: increased sensitivity of molecular diagnosis in comparison to immunohistochemistry.
    Blaheta HJ; Schittek B; Breuninger H; Maczey E; Kroeber S; Sotlar K; Ellwanger U; Thelen MH; Rassner G; Bültmann B; Garbe C
    Int J Cancer; 1998 Aug; 79(4):318-23. PubMed ID: 9699521
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic significance of detecting micrometastases by tyrosinase RT/PCR in sentinel lymph node biopsies: lessons from 322 consecutive melanoma patients.
    Ulrich J; Bonnekoh B; Böckelmann R; Schön M; Schön MP; Steinke R; Roessner A; Schmidt U; Gollnick H
    Eur J Cancer; 2004 Dec; 40(18):2812-9. PubMed ID: 15571965
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of the sentinel lymph node in patients with malignant melanoma: what are the reasons for mistakes?
    Vidal-Sicart S; Pons F; Puig S; Ortega M; Vilalta A; Martín F; Rull R; Palou JM; Castel T
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):362-6. PubMed ID: 12634963
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased detection of metastatic melanoma in pediatric sentinel lymph node biopsies using RT-PCR on paraffin-embedded tissue.
    Somers GR; Chilton-MacNeill S; Zheng K; Stuart M; Pappo A; Zielenska M; Thorner PS
    Appl Immunohistochem Mol Morphol; 2010 Jul; 18(4):365-70. PubMed ID: 20571343
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients.
    Takeuchi H; Morton DL; Kuo C; Turner RR; Elashoff D; Elashoff R; Taback B; Fujimoto A; Hoon DS
    J Clin Oncol; 2004 Jul; 22(13):2671-80. PubMed ID: 15226334
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polymerase chain reaction and immunohistochemistry frequently detect occult melanoma cells in regional lymph nodes of melanoma patients.
    Hatta N; Takata M; Takehara K; Ohara K
    J Clin Pathol; 1998 Aug; 51(8):597-601. PubMed ID: 9828818
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of nonsentinel nodes following completion lymphadenectomy for melanoma.
    Wrightson WR; Wong SL; Edwards MJ; Chao C; Conrad AJ; Albrecht J; Viar V; McMasters KM
    J Surg Res; 2001 Jun; 98(1):47-51. PubMed ID: 11368537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b and Completion Lymph Node Dissection for Patients Staged by Sentinel Lymph Node Biopsy.
    McMasters KM; Egger ME; Edwards MJ; Ross MI; Reintgen DS; Noyes RD; Martin RC; Goydos JS; Beitsch PD; Urist MM; Ariyan S; Sussman JJ; Davidson BS; Gershenwald JE; Hagendoorn LJ; Stromberg AJ; Scoggins CR
    J Clin Oncol; 2016 Apr; 34(10):1079-86. PubMed ID: 26858331
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinicopathological utility of molecular staging for melanoma patients undergoing sentinel lymphadenectomy.
    Takeuchi H; Taback B; Kuo C; Hoon DS
    Ann Surg Oncol; 2004 Mar; 11(3 Suppl):152S-5S. PubMed ID: 15023743
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intraoperative evaluation of sentinel lymph nodes for metastatic melanoma by imprint cytology.
    Creager AJ; Shiver SA; Shen P; Geisinger KR; Levine EA
    Cancer; 2002 Jun; 94(11):3016-22. PubMed ID: 12115392
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Melanoma patient staging: histopathological versus molecular evaluation of the sentinel node.
    Davids V; Kidson SH; Hanekom GS
    Melanoma Res; 2003 Jun; 13(3):313-24. PubMed ID: 12777989
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
    Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
    Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
    [TBL] [Abstract][Full Text] [Related]  

  • 54. "Stealth" melanoma cells in histology-negative sentinel lymph nodes.
    Itakura E; Huang RR; Wen DR; Cochran AJ
    Am J Surg Pathol; 2011 Nov; 35(11):1657-65. PubMed ID: 21997686
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sentinel lymph node biopsy in thin melanoma patients.
    Hershko DD; Robb BW; Lowy AM; Ahmad SA; Ramadas GH; Soldano DA; Sussman JJ
    J Surg Oncol; 2006 Mar; 93(4):279-85. PubMed ID: 16496355
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of melanoma cells in the lymphatic drainage after lymph node dissection in melanoma patients by using two-marker reverse transcriptase-polymerase chain reaction assay.
    Włodzimierz R; Rutkowski P; Nowecki ZI; Kulik J; Nasierowska-Guttmejer A; Siedlecki JA
    Ann Surg Oncol; 2004 Nov; 11(11):988-97. PubMed ID: 15525828
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients.
    Nissan A; Jager D; Roystacher M; Prus D; Peretz T; Eisenberg I; Freund HR; Scanlan M; Ritter G; Old LJ; Mitrani-Rosenbaum S
    Br J Cancer; 2006 Mar; 94(5):681-5. PubMed ID: 16495929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study.
    Gillanders WE; Mikhitarian K; Hebert R; Mauldin PD; Palesch Y; Walters C; Urist MM; Mann GB; Doherty G; Herrmann VM; Hill AD; Eremin O; El-Sheemy M; Orr RK; Valle AA; Henderson MA; Dewitty RL; Sugg SL; Frykberg E; Yeh K; Bell RM; Metcalf JS; Elliott BM; Brothers T; Robison J; Mitas M; Cole DJ
    Ann Surg; 2004 Jun; 239(6):828-37; discussion 837-40. PubMed ID: 15166962
    [TBL] [Abstract][Full Text] [Related]  

  • 59. RT-PCR and immunohistochemical evaluation of sentinel lymph nodes after in vivo mapping with Patent Blue V in colon cancer patients.
    Kelder W; van den Berg A; van der Leij J; Bleeker W; Tiebosch AT; Grond JK; Baas PC; Plukker JT
    Scand J Gastroenterol; 2006 Sep; 41(9):1073-8. PubMed ID: 16938721
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
    Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
    Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.